IAMOG
BIO icon

Investors Asset Management of Georgia’s Bio-Rad Laboratories Class A BIO Stock Holding History

Investors Asset Management of Georgia’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$83K – 214
2022
Q3 		$83K Hold
200
– – 0.04% 233
2022
Q2 		$99K Buy
+200
New +$104K 0.05% 202

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Investors Asset Management of Georgia's BIO Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 200 shares — an estimated $83K sold.

Investors Asset Management of Georgia first reported a position in BIO in Q2 2022 and held it in 2 quarters. The position peaked at $99K in Q2 2022. 472 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Investors Asset Management of Georgia reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 200 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $83K.
  • Investors Asset Management of Georgia first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 2 quarters.
  • Investors Asset Management of Georgia's Bio-Rad Laboratories Class A position peaked at $99K in Q2 2022.
  • 472 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.